{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Praxis Precision Medicines, Inc."},"Symbol":{"label":"Symbol","value":"PRAX"},"Address":{"label":"Address","value":"99 HIGH STREET,30TH FLOOR, BOSTON, Massachusetts, 02110, United States"},"Phone":{"label":"Phone","value":"+1 617 300-8460"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others."},"CompanyUrl":{"label":"Company Url","value":"https://www.praxismedicines.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Karl Hansen","title":"Chief Technical Operations Officer"},{"name":"Marcio Souza","title":"President, Chief Executive Officer & Director"},{"name":"Steven Petrou","title":"Chief Scientific Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}